Navigation Links
Video: 8-Minute Film Documentary Explores Why Humans Age
Date:11/28/2008

SAN DIMAS, Calif., Nov. 28 /PRNewswire/ --Why Humans Age is the title of an 8-minute documentary film narrated by Bill Sardi, co-founder and formulator of Longevinex(R) (long-jev-in-ex), a nutriceutical product designed to promote healthy aging.

To view the Multimedia News Release, go to:

http://www.prnewswire.com/mnr/longevinex/35829/

The film presents the "overmineralization" theory of aging -- that humans begin to age biologically only after full childhood growth is achieved.

While there are many theories of aging (hormonal, free radical, wear and tear), the overmineralization theory is the only explanation for why humans age at three different speeds:

  1. no biological aging during the childhood growth years, characterized by the shuttling of calcium, iron and copper to make new bones, red blood cells and collagen;
  2. accumulation of these minerals once childhood growth has ceased and progressive aging, as evidenced by the buildup of cellular debris called lipofuscin;
  3. a slight decline in the rate of aging in late life, which has been correlated with reaching a steady state of minerals. For example, iron stores do not increase any further.

The film explains why women live, on average, about 5 to 8 years longer than males. Women do not begin to accumulate minerals until they have reached menopause. During their fertile years, losses of iron and copper during menstruation, and donation of calcium to offspring, explains why women avoid the "rusting and calcification" seen in full-grown males.

The film explains why males at age 40 have double the amount of iron and four times as much calcium in their bodies compared to an equally aged female, and experience double the rate of diabetes, cancer and heart disease.

The film demonstrates how natural mineral chelating (key-lay-ting) molecules, such as those provided in Longevinex(R), can reduce overmineralization and turn back the clock hands of biological time.

The film depicts a first-of-its-kind experiment where measurement of lipofuscin was performed by direct photography of the retina at the back of the eyes of an 80-year old man, and then Longevinex(R) was employed for 5 months, and was found to reduce cellular debris (lipofuscin). This intervention correlated with improvement in five measurable parameters of vision (visual acuity, night, color, contrast and side vision).

The film suggests a day when retinal photographs will measure lipofuscin levels to determine the biological age of an individual, and natural mineral-chelating molecules will be employed to turn back biological time. The removal of lipofuscin would remove any theoretical limits on the maximum achievable lifespan of humans.

The film was produced by Michael Gonzales and Associates and is available for viewing at www.longevinex.com.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.


'/>"/>
SOURCE Longevinex(R)
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Video: Insulet Unveils Video Contest for OmniPod Users
2. Video: OneTouch(R) Teams With Online Diabetes Community to Launch Global Diabetes Handprint Project
3. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
4. Video: Women Unsatisfied With Body and Breasts, Less Likely to Comply With Screenings, Including Mammography
5. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder
6. Video: Fortune 1000 Executives: New President Must Fix Education Gap
7. Video: Keppra XR(TM) Approved in the U.S.
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
10. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
11. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... Ovation ... infertility as a disease, bringing new hope for prospective parents who are challenged ... meeting to back the World Health Organization’s designation in hopes of changing the ...
(Date:6/22/2017)... Lawrence, MA (PRWEB) , ... June 22, 2017 , ... ... completed ILVO validation. The AMPH test was determined to be appropriate as a screening ... for visual interpretation, on the Charm EZ system, and the Charm EZ Lite system. ...
(Date:6/20/2017)... ... June 20, 2017 , ... National ... well-versed leader with extensive assay development and biomarker expertise, as VP of Scientific ... Boston CRO specializing in bio-analytical assay development and sample testing services. The organization ...
(Date:6/19/2017)... ... June 19, 2017 , ... Tunnell Consulting has been solving the ... the biggest challenges faced by life sciences, biotech and pharmaceuticals companies today is in ... Kati Abraham , who is well known in the industry and brings significant high-level ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):